维普期刊资源整合服务平台（V6.5）

85篇 您的检索式：作者名="Portas C M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Recombinant human interleukin-11 (neumega, rhIL11) reduces thrombocytopenia in breast cancer patients receiving tandem autolous circulating progenitor cell transportation 显示文摘	Ferrari S Danova M Porta C	2002	Ann Hematol2002，81，6：	1
2	Circulating interleukin-6as a tumor marker for hepatocellular carcinoma显示文摘	Porta C De Amici M Quaglini S	2008	Ann Oncol2008，19，2：	1
3	Endothelin-1 and 5-fluoroura- cil-induced cardiotoxicity显示文摘	Porta C Moroni M Ferrari S	1998	Neoplasma1998，45，2：	1
4	Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System(WPSS)显示文摘	Malcovati L Della Porta M G Strupp C	2011	Haematologica2011，96，10：	1
5	Trends in pancreatic cancer mortality in Europe 显示文摘	Fernandez E La Vecchina C Porta M	1994	Int J Cancer1994，57，6：	1
6	Safety and efficacy of sunitinib for metastatic renal-cell carcinoma:an expanded-access trial显示文摘	Gore M E Szczylik C Porta C	2009	Lancet Oncol2009，10，8：	1
7	Sunitinib in metastatic renal cell carcinoma patients with brain metastases 显示文摘	GORE M E HARIHARAN S PORTA C	2011	Cancer2011，117，3：	1
8	Gene polymorphisms infolate metabolizing enzymes in adult acute lymphoblasticleukemia:effects on methotrexate-related toxicity and sur-vival显示文摘	Ongaro A De Mattei M Della Porta MG Rigolin G Am-brosio C Di Raimondo F	2009	Haematologica2009，94，10：	1
9	Tolerance and M2 (alternative)macrophage polarization are related processes orchestrated by p50nuclear factor kappaB 显示文摘	Porta C Rimoldi M Raes G	2009	Proc Natl Acad Sci USA2009，106，14：	1
10	Interferons alphaand gamma induce p53-dependent and p53-independent apop- tosis, respectively 显示文摘	Porta C Hadj SR Nejmeddine M	2005	Oncogene2005，24，4：	1
11	5-Fluorouracil and d,1-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients:preliminary results of a phase II study显示文摘	Porta C Moroni M Nastasi G		0，，06：	1
12	Renal cell carcino- ma:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 显示文摘	Escudier B Porta C Schmidinger M	2014	Ann Oncol2014，253，：	1
13	Phase defects and spatiotemporal di~rder in traveling-wave convection patterns显示文摘	PORTA A L SURKO C M	1997	Phys Rev E1997，56，：	1
14	Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma显示文摘	Gore M E Szczylik C Porta C Bracarda S Bjarnason G A Oudard S	2015	Br J Cancer2015，113，：	1
15	Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) 显示文摘	MALCOVATI L DELLA PORTA M G STRUPP C A	2011	Haematologica-- The Hematology Journal2011，96，10：	1
16	In vitro antioxidant properties of amifostine (WR-2721,Ethyol)显示文摘	Marzatico F Porta C Moroni M	2000	Cancer Chemother Pharmacol2000，45，2：	1
17	Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial显示文摘	Gore M E Szczylik C Porta C Bracarda S Bjarnason G A Oudard S	2009	Lancet Oncol2009，10，：	1
18	5 - Fluorouracil and 1 - leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase Ⅱ study 显示文摘	Porta C Moroni M Nastasi G	1995	Oncology1995，51，6：	1
19	Recombinant human interleukin-11 (Neumega,rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation显示文摘	Ferrari S Danova M Porta C	2002	Ann Hematol2002，81，6：	1
20	Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively 显示文摘	Porta C Hadj-Slimane R Nejmeddine M	2005	Oncogene2005，24，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示